Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland

International Journal of Antimicrobial Agents

Volumn 45, Issue 3, 2015, Pages 238-243

  Piekarska, Katarzyna ^a   Wołkowicz, Tomasz ^a   Zacharczuk, Katarzyna ^a   Rzeczkowska, Magdalena ^a   Chróst, Anna ^a   Bareja, Elzbieta ^b   Olak, Monika ^b   Gierczyński, Rafał ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Enterobacteriaceae; PMQR; Poland; QRDR mutations

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; MUTANT PROTEIN; QUINOLONE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; GENE; GENE MUTATION; GYRA GENE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; PARC GENE; PLASMID; POLAND; PRIORITY JOURNAL; TERTIARY CARE CENTER; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTANT PROTEINS; PLASMIDS; POLAND; PROSPECTIVE STUDIES; QUINOLONES; TERTIARY CARE CENTERS;

EID: 84923650113     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.09.019     Document Type: Article

References (25)

1. European Centre for Disease Prevention and Control. European Antimicrobial Resistance Surveillance Network (EARS-Net) annual report. Antimicrobial resistance surveillance in Europe 2011. http://www.ecdc.europa.eu [accessed 30 October 2014].
2. D.C. Hooper Mechanisms of fluoroquinolone resistance Drug Resist Updat 2 1999 38 55
3. P. Nordmann, and L. Poirel Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae J Antimicrob Chemother 56 2005 463 469
4. L. Poirel, V. Cattoir, and P. Nordmann Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies Front Microbiol 3 2012 24
5. A. Briales, J.M. Rodríguez-Martínez, C. Velasco, P. Díaz de Alba, J. Rodríguez-Baño, and L. Martínez-Martínez Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain Int J Antimicrob Agents 39 2012 431 434
6. H. Fang, H. Huang, Y. Shi, G. Hedin, C.E. Nord, and M. Ullberg Prevalence of qnr determinants among extended-spectrum β-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden Int J Antimicrob Agents 34 2009 268 270
7. H. Yang, H. Chen, Q. Yang, M. Chen, and H. Wang High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6′)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospital in China Antimicrob Agents Chemother 52 2008 4268 4273
8. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition. Document M07-A8. Wayne, PA: CLSI; 2009.
9. V. Cattoir, L. Poirel, V. Rotami, C.J. Soussy, and P. Nordmann Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates J Antimicrob Chemother 60 2007 394 397
10. C.H. Park, A. Robisek, G.A. Jakoby, D. Sahm, and D.C. Hooper Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme Antimicrob Agents Chemother 50 2006 3953 3955
11. K. Yamane, J. Wachino, S. Suzuki, and Y. Arakawa Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan Antimicrob Agents Chemother 52 2008 1564 1566
12. M. Wang, Q. Guo, X. Xu, X. Wang, X. Ye, and S. Wu New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis Antimicrob Agents Chemother 53 2009 1892 1897
13. L.M. Cavaco, H. Hasman, S. Xia, and F.M. Aarestrup qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin Antimicrob Agents Chemother 53 2009 603 608
14. J.M. Rodríguez-Martínez, C. Velasco, A. Pascual, I. García, and L. Martínez-Martínez Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids Clin Microbiol Infect 12 2006 440 445
15. K. Zacharczuk, K. Piekarska, J. Szych, M. Jagielski, L. Hidalgo, and ÁS Millán Plasmid-borne 16S rRNA methylase ArmA in aminoglycoside-resistant Klebsiella pneumoniae in Poland J Med Microbiol 60 2011 1306 1311
16. S. Bansal, and V. Tandon Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates Int J Antimicrob Agents 37 2011 253 255
17. A.M. Shibl, M.H. Al-Agamy, H. Khubnani, A.C. Senok, A.F. Tawfik, and D.M. Livermore High prevalence of acquired quinolone-resistance genes among Enterobacteriaceae from Saudi Arabia with CTX-M-15 β-lactamase Diagn Microbiol Infect Dis 73 2012 350 353
18. S. Dahmen, L. Poirel, W. Mansour, O. Bouallèuge, and P. Nordmann Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia Clin Microbiol Infect 16 2010 1019 1023
19. Y. Luo, J. Yang, Y. Zhang, L. Ye, L. Wang, and L. Guo Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants Int J Antimicrob Agents 37 2011 352 355
20. P. Andres, C. Lucero, A. Soler-Bistué, L. Guerriero, E. Albornoz, and T. Tran Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina Antimicrob Agents Chemother 57 2013 2467 2475
21. H. Yoshida, M. Bogaki, M. Nakamura, and S. Nakamura Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli Antimicrob Agents Chemother 34 1990 1271 1272
22. Y.S. Nam, S.Y. Cho, H.Y. Yang, K.S. Park, J-H. Jang, and Y-T. Kim Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010 Int J Antimicrob Agents 41 2013 126 129
23. G.A. Jacoby Mechanisms of resistance to fluoroquinolone Clin Infect Dis 41 Suppl 2 2005 S120 S126
24. J.M. Ling, E.W. Chan, A.W. Lam, and A.F. Cheng Mutation in topoisomerase genes of fluoroquinolone-resistant Salmonella in Hong Kong Antimicrob Agents Chemother 47 2003 3567 3573
25. Y. Fu, W. Zhang, H. Wang, S. Zhao, Y. Chen, and F. Meng Specific patterns of gyrA mutations determine resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli BMC Infect Dis 13 2013 8